Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis
Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis
Recruiting · NCT02842424 · Registry updated 2025-05-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ramipril Treatment of Claudication: Oxidative Damage and Muscle Fibrosis | Arterial Occlusive Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, arteriosclerosis disorder, atherosclerosis, cardiovascular disorder, intermittent vascular claudication, muscle tissue disorder, musculoskeletal system disorder, nervous system disorder, neuromuscular disease, peripheral arterial disease, peripheral vascular disease, vascular disorder | Recruiting | Phase 4 | 2025-05-23 | NCT02842424 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Nebraska | 106 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| VA Medical Center | Omaha | United States | 2 |